Literature DB >> 32892306

miR-30c-5p Alleviated Pyroptosis During Sepsis-Induced Acute Kidney Injury via Targeting TXNIP.

Xiang Li1, Linya Yao2, Xueming Zeng2, Bing Hu2, Xi Zhang2, Jun Wang2, Runyu Zhu2, Qiwei Yu2.   

Abstract

Sepsis-induced acute kidney injury (SAKI) is a common complication of hospitalized patients, often leading to unacceptable mortality. Limited effective treatment or diagnosis biomarkers are available and the underlying mechanism remains unclear. The miR-30c-5p is considered as a critical mediator of kidney diseases and aberrantly decreased in patients with SAKI, while the mechanism is still unclear. For this purpose, the role of miR-30c-5p in SAKI has been investigated in this study. Here, we first confirmed that miR-30c-5p expression decreased in our septic models and was associated with the activation of NLRP3/caspase-1-mediated pyroptosis. Overexpression of miR-30c-5p alleviated the kidney injury via suppressing HK-2 cell pyroptosis. Furthermore, we identified that TXNIP was a direct target of miR-30c-5p. Upregulation of miR-30c-5p repressed the expression of TXNIP, which inhibited NLRP3, ASC, and caspase-1 expression, as well as secretion of inflammatory cytokines. In conclusion, our data suggested that miR-30c-5p negatively controlled the NLRP3 signal pathway-related pyroptosis and sepsis-induced injury via TXNIP, indicating that this axis might be a positive therapeutic target for the patient with SAKI.

Entities:  

Keywords:  TXNIP; miR-30c-5p; pyroptosis; sepsis-induced acute kidney injury

Year:  2021        PMID: 32892306     DOI: 10.1007/s10753-020-01323-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

1.  miRNA-23a has effects to improve lung injury induced by sepsis in vitro and vivo study.

Authors:  Jing Yang; Min Mao; Yuan-Yuan Zhen
Journal:  Biomed Pharmacother       Date:  2018-08-03       Impact factor: 6.529

Review 2.  Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.

Authors:  Sadudee Peerapornratana; Carlos L Manrique-Caballero; Hernando Gómez; John A Kellum
Journal:  Kidney Int       Date:  2019-06-07       Impact factor: 10.612

Review 3.  Acute kidney injury.

Authors:  Claudio Ronco; Rinaldo Bellomo; John A Kellum
Journal:  Lancet       Date:  2019-11-23       Impact factor: 79.321

Review 4.  Acute kidney injury in sepsis.

Authors:  Rinaldo Bellomo; John A Kellum; Claudio Ronco; Ron Wald; Johan Martensson; Matthew Maiden; Sean M Bagshaw; Neil J Glassford; Yugeesh Lankadeva; Suvi T Vaara; Antoine Schneider
Journal:  Intensive Care Med       Date:  2017-03-31       Impact factor: 17.440

Review 5.  Sepsis-induced acute kidney injury.

Authors:  Hernando Gómez; John A Kellum
Journal:  Curr Opin Crit Care       Date:  2016-12       Impact factor: 3.687

Review 6.  The Potential of MicroRNAs as Prostate Cancer Biomarkers.

Authors:  Linda Fabris; Yvonne Ceder; Arul M Chinnaiyan; Guido W Jenster; Karina D Sorensen; Scott Tomlins; Tapio Visakorpi; George A Calin
Journal:  Eur Urol       Date:  2016-01-22       Impact factor: 20.096

Review 7.  MicroRNA.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-10-23       Impact factor: 10.793

Review 8.  Mechanisms and treatment of organ failure in sepsis.

Authors:  Christophe Lelubre; Jean-Louis Vincent
Journal:  Nat Rev Nephrol       Date:  2018-07       Impact factor: 28.314

Review 9.  Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers.

Authors:  Perry V Halushka; Andrew J Goodwin; Marc K Halushka
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

Review 10.  Prognostic and predictive enrichment in sepsis.

Authors:  Natalja L Stanski; Hector R Wong
Journal:  Nat Rev Nephrol       Date:  2019-09-11       Impact factor: 28.314

View more
  12 in total

1.  The Potential of miR-370-3p and miR-495-3p Serving as Biomarkers for Sepsis-Associated Acute Kidney Injury.

Authors:  Wenlu Ma; Xiaomei Miao; Fangfang Xia; Chao Ruan; Dan Tao; Bing Li
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

2.  Urinary microRNAome in healthy cats and cats with pyelonephritis or other urological conditions.

Authors:  Marta Gòdia; Louise Brogaard; Emilio Mármol-Sánchez; Rebecca Langhorn; Ida Nordang Kieler; Bert Jan Reezigt; Lise Nikolic Nielsen; Lisbeth Rem Jessen; Susanna Cirera
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

Review 3.  The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target.

Authors:  Alison Domingues; Julia Jolibois; Perrine Marquet de Rougé; Valérie Nivet-Antoine
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

4.  Rehabilitation of Sepsis Patients with Acute Kidney Injury Based on Intelligent Medical Big Data.

Authors:  Yanmei Xia; Xiuzhe Wang; Weidong Wu; Haipeng Shi
Journal:  J Healthc Eng       Date:  2022-01-07       Impact factor: 2.682

5.  Evaluation System of Smart Logistics Comprehensive Management Based on Hospital Data Fusion Technology.

Authors:  Biwen Yao; Huiming Wang; Mingliang Shao; Jian Chen; Guo Wei
Journal:  J Healthc Eng       Date:  2022-01-07       Impact factor: 2.682

6.  Evaluation of the Effect of PDCA in Hospital Health Management.

Authors:  Huanmin Qiu; Weiwei Du
Journal:  J Healthc Eng       Date:  2021-12-20       Impact factor: 2.682

Review 7.  The Programmed Cell Death of Macrophages, Endothelial Cells, and Tubular Epithelial Cells in Sepsis-AKI.

Authors:  Chao Li; Wei Wang; Shuai-Shuai Xie; Wen-Xian Ma; Qian-Wen Fan; Ying Chen; Yuan He; Jia-Nan Wang; Qin Yang; Hai-di Li; Juan Jin; Ming-Ming Liu; Xiao-Ming Meng; Jia-Gen Wen
Journal:  Front Med (Lausanne)       Date:  2021-12-02

Review 8.  Non-Coding RNAs in Sepsis-Associated Acute Kidney Injury.

Authors:  Yanna Chen; Huan Jing; Simin Tang; Pei Liu; Ye Cheng; Youling Fan; Hongtao Chen; Jun Zhou
Journal:  Front Physiol       Date:  2022-04-08       Impact factor: 4.755

9.  Neutrophil membrane engineered HucMSC sEVs alleviate cisplatin-induced AKI by enhancing cellular uptake and targeting.

Authors:  Peipei Wu; Yuting Tang; Can Jin; Min Wang; Linli Li; Zhong Liu; Hui Shi; Zixuan Sun; Xiaomei Hou; Wenya Chen; Wenrong Xu; Hui Qian
Journal:  J Nanobiotechnology       Date:  2022-08-01       Impact factor: 9.429

10.  Diagnostic Value of SonoVue Contrast-Enhanced Ultrasonography in Nipple Discharge Based on Artificial Intelligence.

Authors:  Ling Guo
Journal:  J Healthc Eng       Date:  2021-12-16       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.